YTHDF3 and hepatocellular carcinoma: The Kaplan–Meier analysis of 238 HCC patients from Sun Yat-sen Memorial Hospital indicated overexpression of YTHDF3 was correlated to poorer overall survival of HCC patients (log-rank = 5.104, P = 0.0239), and the median survival time of the YTHDF3 low-expression group was about 42.85 months, which was apparently longer than that in YTHDF3 high-expression group (about 33.95 months) (Fig. 1h upper).